Washington – After additional negotiations with the food and drug administration, Novovax’s closely seen Covid -1 vaccine is on the verge of fully approval, the company said on Wednesday.
The news has sent the company shares to more than 21% of the morning trading, and the Trump administration officials have been shown to solve anxiety that can make a decision with a shot.
Novovax produces the only traditional -based protein -based Covid -19 vaccine in the country. It is still selling under emergency use approval – FiSer and Modner -made MRNA vaccines that have achieved full FDA approval for a certain age.
The FDA has recently asked Novovax to create a plan to collect additional clinical data from those who have acquired the shot, the company said in a statement. It says it is “FDA involved in fast” in the hope of “as soon as possible” approval.
In the FDA, the full vaccine is the approval of the gold value. According to the two direct knowledge of the situation on the condition of anonymity, the agency was on his way to sign up in Novavax’s license by April 1, according to the two direct knowledge of the situation.
However, the FDA’s acting commissioner Dr Sara Sara directed the brainer agency chief officer to monitor the vaccine to break the decision, according to one. The first delay by the Wall Street Journal initiated the concern of political intervention under Robert F. Kennedy Jr, who spent decades of leadership in the antivaccin groups before joining the Federal Government as a health secretary.
Last month, FDA’s long -term vaccine chief. Peter Marx was forced to disagree with Kennedy about vaccine protection.
With full FDA approval, Novavax’s shot will be allowed to be kept indefinitely in the market. Emergency approved products can be removed after the FDA does not have health emergency condition.
All Covid -19 vaccines used in the United States trained the body to fight Coronavirus its outer cover, spike protein.
Fizzer and Modern options temporarily provide genetic instructions for the body to create a copy of protein. On the contrary, the Novavax vaccine uses a lab-enhanced copy of the spike protein packaged in nano Particles and combines with a resistant power-recovery material. Protein-based vaccines are used for years to prevent other diseases including hepatitis B and pendant.
Every year, three manufacturers update their vaccine recipes and the latest Covid -19 variants are aired as flu shots are updated annually.
___
Associated Press Health and Science Department has received the support of the Science and Educational Media Group and Robert Wood Johnson Foundation of the Hughes Medical Institute. AP is the sole responsible for all content.
Leave a Reply